We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.
- Authors
Werbel, William A.; Boyarsky, Brian J.; Ou, Michael T.; Massie, Allan B.; Tobian, Aaron A.R.; Garonzik-Wang, Jacqueline M.; Segev, Dorry L.
- Abstract
I Objective: i To describe antibody responses and vaccine reactions in recipients of solid organ transplants who had a suboptimal response to standard vaccination and subsequently received a third dose of vaccine between 20 March 2021 and 10 May 2021. I Background: i The antibody response after 2 doses of an mRNA vaccine against SARS-CoV-2 is excellent in the general population ([1]), but the response is different in recipients of solid organ transplants. It is encouraging that antibody titers increased after the third dose in one third of patients who had negative antibody titers and in all patients who had low-positive antibody titers.
- Subjects
TRANSPLANTATION of organs, tissues, etc.; SARS-CoV-2; VACCINES; COVID-19; HEART transplant recipients; HEPATITIS B vaccines
- Publication
Annals of Internal Medicine, 2021, Vol 174, Issue 9, p1330
- ISSN
0003-4819
- Publication type
letter
- DOI
10.7326/L21-0282